These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 10744925)

  • 1. Neuropsychological and behavioral aspects of transplants in Parkinson's disease and Huntington's disease.
    Diederich NJ; Goetz CG
    Brain Cogn; 2000 Mar; 42(2):294-306. PubMed ID: 10744925
    [No Abstract]   [Full Text] [Related]  

  • 2. [Simultaneous micro-transplantation of fetal mesencephalic cells to the striate and substantia nigra pars reticulata in hemi-parkinsonian rats. A study of behavior].
    Blanco L; Pavón N; Macías R; Castillo L; Díaz C; García A; Alvarez P
    Rev Neurol; 2000 Jun 16-30; 30(12):1122-7. PubMed ID: 10935235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intraparenchymal and intraventricular transplantation of fetal substantia nigra cell suspension in rat model of Parkinson's disease].
    Yang H; Zhang K; Cai W
    Zhonghua Wai Ke Za Zhi; 1997 Jan; 35(1):19-21. PubMed ID: 10374501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of neurotransplants in humans.
    Blüml S; Kopyov O; Jacques S; Ross BD
    Exp Neurol; 1999 Jul; 158(1):121-5. PubMed ID: 10448423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathology of fetal nigral grafts in patients with Parkinson's disease.
    Kordower JH; Freeman TB; Olanow CW
    Mov Disord; 1998; 13 Suppl 1():88-95. PubMed ID: 9613724
    [No Abstract]   [Full Text] [Related]  

  • 6. Implanting fetal tissue to treat Parkinson's disease.
    Breeze RE
    West J Med; 1990 Nov; 153(5):543-4. PubMed ID: 2260291
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety of intrastriatal neurotransplantation for Huntington's disease patients.
    Kopyov OV; Jacques S; Lieberman A; Duma CM; Eagle KS
    Exp Neurol; 1998 Jan; 149(1):97-108. PubMed ID: 9454619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical neurotransplantation protocol for Huntington's and Parkinson's disease.
    Lopez WO; Nikkhah G; Kahlert UD; Maciaczyk D; Bogiel T; Moellers S; Schültke E; Döbrössy M; Maciaczyk J
    Restor Neurol Neurosci; 2013; 31(5):579-95. PubMed ID: 23777636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repair of the damaged brain. The Alfred Meyer Memorial Lecture 1998.
    Dunnett SB
    Neuropathol Appl Neurobiol; 1999 Oct; 25(5):351-62. PubMed ID: 10564524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating fetal neural transplants into a therapeutic strategy: the example of Huntington's disease.
    Peschanski M; Bachoud-Lévi AC; Hantraye P
    Brain; 2004 Jun; 127(Pt 6):1219-28. PubMed ID: 15047588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striatal calcium channel antagonist receptors in Huntington's disease and Parkinson's disease.
    Watson DL; Carpenter CL; Marks SS; Greenberg DA
    Ann Neurol; 1988 Mar; 23(3):303-5. PubMed ID: 2967667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compactotomy in Huntington's chorea.
    Bonelli RM; Kenner L; Gruber A; Reisecker F; Költringer P
    Med Hypotheses; 2001 Oct; 57(4):491-6. PubMed ID: 11601877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intranigral vs intrastriatal fetal mesencephalic neural grafts on motor behavior disorders in a rat Parkinson model.
    Goren B; Kahveci N; Eyigor O; Alkan T; Korfali E; Ozluk K
    Surg Neurol; 2005; 64 Suppl 2():S33-41. PubMed ID: 16256839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Core Assessment Program for Intracerebral Transplantation in Huntington's Disease (CAPIT-HD).
    Quinn N; Brown R; Craufurd D; Goldman S; Hodges J; Kieburtz K; Lindvall O; MacMillan J; Roos R
    Mov Disord; 1996 Mar; 11(2):143-50. PubMed ID: 8684383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplantation of fetal mesencephalic tissue in Parkinson's disease.
    Freed CR; Breeze RE; Schneck SA
    N Engl J Med; 1995 Sep; 333(11):730-1. PubMed ID: 7637761
    [No Abstract]   [Full Text] [Related]  

  • 16. [Surgical treatment of Parkinson's disease as a supplement to pharmacological therapy].
    Jabłońska B; Dabek J; Lepich T
    Wiad Lek; 2006; 59(11-12):823-8. PubMed ID: 17427499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intracerebral transplantation of immature substantia nigra in rats with experimentally induced Parkinson's disease. II. Results of histopathological and histofluorescent studies.
    Dymecki J; Półtorak M; Puciłowski O; Markiewicz D; Kostowski W
    Neuropatol Pol; 1985; 23(2):181-9. PubMed ID: 3930995
    [No Abstract]   [Full Text] [Related]  

  • 18. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethical aspects of neural tissue transplantation.
    Hildt E
    Croat Med J; 1999 Sep; 40(3):326-33. PubMed ID: 10411958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell transplantation for Huntington's disease.
    Sanberg PR; Koutouzis TK; Freeman TB; Emerich DF; Bertino AM; Cahill DW
    Transplant Proc; 1992 Dec; 24(6):3015-6. PubMed ID: 1361271
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.